Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Alimera Sciences Inc (NQ: ALIM )

3.630 +0.190 (+5.52%)
Streaming Delayed Price Updated: 10:30 AM EDT, Apr 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Alimera Sciences Inc

< Previous 1 2 Next >
ALIM Stock Earnings: Alimera Sciences Beats Revenue for Q4 2023
ALIM stock results show that Alimera Sciences beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
The Latest Analyst Ratings for Alimera Sciences
Via Benzinga
Preview: Alimera Sciences's Earnings
Via Benzinga
Stonegate Capital Partners Announces Publishing of a Thematic Report - Undervalued Growth Pharma Companies Amidst Healthcare Sector Decline
Dallas, Texas--(Newsfile Corp. - August 8, 2023) - Stonegate is pleased to announce the... 
Via Newsfile
Alliance Global Partners Upgrades Alimera Sciences: Here's What You Need To Know
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 12, 2023
Via Benzinga
Expert Ratings for Alimera Sciences
Via Benzinga
Earnings Scheduled For March 7, 2024
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million. 
Via Benzinga
A Preview Of Alimera Sciences's Earnings
Via Benzinga
10 Short Squeeze Stocks To Watch: Getty Images, Intuitive Machines, Wearable Devices & More
Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a focus of new traders looking for the next huge move. High short interest and steep borrowing costs are among... 
Via Benzinga
Why Foot Locker Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Monogram Orthopaedics Inc. (NASDAQ: MGRM) shares climbed 148.3% to $29.18 after jumping 62% on Thursday. Monogram Orthopaedics raised $17,216,147 through the sale of 2,374,641 shares of its... 
Via Benzinga
4 Analysts Have This to Say About Alimera Sciences
Via Benzinga
Earnings Outlook For Alimera Sciences
Via Benzinga
Looking Into Alimera Sciences's Return On Capital Employed
Via Benzinga
Recap: Alimera Sciences Q1 Earnings
Alimera Sciences (NASDAQ:ALIM) reported its Q1 earnings results on Monday, May 9, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why DXC Technology Shares Are Trading Lower By Around 5%; Here Are 20 Stocks Moving Premarket
Gainers Monogram Orthopaedics Inc. (NASDAQ: MGRM) shares surged 163.7% to $30.98 in pre-market trading after jumping 62% on Thursday. Monogram Orthopaedics raised $17,216,147 through the sale of... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's time to start off the final day of the trading week with a breakdown of the biggest pre-market stock movers for Friday! 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why Monro Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers CaliberCos Inc. (NASDAQ: CWD) shares jumped 65.6% to $9.94 amid post-IPO volatility. 
Via Benzinga
Why Is Alimera Sciences (ALIM) Stock Up 21% Today?
Alimera Sciences (ALIM) stock is taking off on Thursday after signing a major deal with EyePoint Pharmaceuticals (EYPT). 
Via InvestorPlace
US Stocks Mixed; Jobless Claims Drop More than Projected
U.S. stocks traded mixed this morning, with the Dow Jones dropping around 100 points on Thursday. Following the market opening Thursday, the Dow traded down 0.31% to 33,315.53 while the NASDAQ rose... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
EyePoint Pharma Offloads Its Commercially-Available Eye Implant For $82.5M Plus Royalties
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) has agreed to sell Yutiq (fluocinolone acetonide intravitreal implant) 0.18mg to Alimera Sciences Inc (NASDAQ: ALIM).  
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
7 Stocks That Could Implode at Any Moment
Although it’s a party-pooper topic, the vagaries of the market dictates that investors should be aware of these stocks to sell. 
Via InvestorPlace
Stocks That Hit 52-Week Lows On Tuesday
  During Tuesday, 79 stocks hit new 52-week lows. 
Via Benzinga
Alimera Sciences: Q2 Earnings Insights
  Alimera Sciences (NASDAQ:ALIM) reported its Q2 earnings results on Wednesday, July 27, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
36 of the Best Ideas Companies to Present at the 2nd Annual Winter Wonderland Virtual Investor Conference on February 8th - 11th, 2022
RALEIGH, NC / ACCESSWIRE / January 28, 2022 / The Winter Wonderland Best Ideas Virtual Investor Conference will take place on February 8th - 11th, 2022, where 36 SmallCap, MicroCap and NanoCap public... 
From MicroCap Rodeo
Via AccessWire
2 Moonshots That Insiders Are Buying… and 3 They’re Not
The first several days of November saw insiders spend nearly $750 million buying up shares of their companies, which is worth your attention. 
Via InvestorPlace
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.